Pfizer Phase 3 Respiratory Syncytial Virus (RSV) Clinical Trial
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Respiratory Syncytial Virus
-
Age: Between 18 years - 110 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
We are enrolling two substudy groups based on participant medical history.- Substudy A: Adults between 18-59 years who meet ONE OR BOTH of the
following criteria:
- Currently living with one or more chronic health disorders (can include pulmonary, cardiovascular, renal, hepatic, neurologic, hematologic, and/or metabolic disorders) for more than 6 months; OR
- Currently living in a nursing home or other-long term care facility.
- Substudy B: Adults over 18 years, who meet ONE of the following criteria:
- Currently in treatment for advanced NSCLC; OR
- Currently undergoing maintenance hemodialysis secondary to endstage renal disease; OR
- Currently on active immunomodulator therapy; OR
- Received a kidney, liver, lung, or heart transplant at least 3 months ago.
You may not be eligible for this study if the following are true:
-
- Substudy A:
- History of isolated hypertension; AND/OR
- Significant change to your chronic disease therapy in the past 6 weeks; AND/OR
- Hospitalization in the 12 weeks before the study.
- Substudy B:
- Receipt or planned receipt of blood/plasma products or immunoglobulin 60 days before and during the course of the study.
- History of transplant rejection or treatment for rejection within 3 months before study.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.